Stumbling blocks on the path to personalized medicine in breast cancer: the case of PARP inhibitors for BRCA1/2-associated cancers. [electronic resource]
Producer: 20121019Description: 29-34 p. digitalISSN:- 2159-8290
- Antineoplastic Agents -- therapeutic use
- BRCA1 Protein -- metabolism
- BRCA2 Protein -- metabolism
- Breast Neoplasms -- drug therapy
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Drug Evaluation, Preclinical
- Humans
- Molecular Targeted Therapy -- methods
- Poly(ADP-ribose) Polymerase Inhibitors
- Poly(ADP-ribose) Polymerases -- metabolism
- Precision Medicine -- methods
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.